| P50 | author | Nate Watson | Q86549820 |
| P2093 | author name string | Cesar V Borlongan | |
| | Chiara Gonzales-Portillo | |
| | Theo Diamandis | |
| | Stephanny Reyes | |
| P2860 | cites work | Beneficial effects of green tea: a literature review | Q21203064 |
| | A Review of the Multiple Actions of Melatonin on the Immune System | Q22306049 |
| | Monitoring glutamate release during LTP with glial transporter currents | Q46651596 |
| | Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice | Q46961850 |
| | Severe instead of mild hyperglycemia inhibits neurogenesis in the subventricular zone of adult rats after transient focal cerebral ischemia | Q48101343 |
| | Effects of melatonin on histomorphology and on the expression of steroid receptors, VEGF, and PCNA in ovaries of pinealectomized female rats. | Q48138820 |
| | Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia | Q48212116 |
| | Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats. | Q48248885 |
| | Neuroprotective activity of lavender oil on transient focal cerebral ischemia in mice. | Q48408487 |
| | Melatonin-induced enhancement of antibody-dependent cellular cytotoxicity | Q48755402 |
| | Melatonin protects neurons from singlet oxygen-induced apoptosis. | Q50761811 |
| | Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers | Q24795063 |
| | Cellular replacement therapy for Parkinson's disease--where we are today? | Q28206557 |
| | A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease. | Q30365907 |
| | The changing landscape of ischaemic brain injury mechanisms. | Q33678157 |
| | Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats | Q33841270 |
| | High physiological levels of melatonin in the bile of mammals | Q34506503 |
| | Neural transplantation for treatment of Parkinson's disease. | Q34731427 |
| | The rat retina has five types of ganglion-cell photoreceptors. | Q34771505 |
| | Effect of lavender oil (Lavandula angustifolia) on cerebral edema and its possible mechanisms in an experimental model of stroke. | Q35079622 |
| | Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation | Q35789004 |
| | Beneficial effects of melatonin on stroke-induced muscle atrophy in focal cerebral ischemic rats | Q35860290 |
| | Melatonin-based therapeutics for neuroprotection in stroke | Q36913537 |
| | Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages | Q37224612 |
| | Ramelteon: a review of its use in insomnia | Q37253022 |
| | Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke | Q37354712 |
| | The Antidepressant Agomelatine Improves Memory Deterioration and Upregulates CREB and BDNF Gene Expression Levels in Unpredictable Chronic Mild Stress (UCMS)-Exposed Mice | Q37628699 |
| | Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles | Q37656414 |
| | Melatonin: a multitasking molecule | Q37755679 |
| | Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists. | Q37763715 |
| | Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies | Q37919706 |
| | Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives | Q38172120 |
| | Upregulation of CREB-mediated transcription enhances both short- and long-term memory. | Q39523847 |
| | In vitro and in vivo antitumor activity of melatonin receptor agonists | Q39683381 |
| | Melatonin regulates the viability and differentiation of rat midbrain neural stem cells | Q40072721 |
| | Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease | Q40084730 |
| | Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice | Q40122566 |
| | Protective effects of melatonin in mice infected with encephalitis viruses | Q40692005 |
| | The immunoneuroendocrine role of melatonin | Q40902211 |
| | Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia | Q41274062 |
| | Transplantation of cultured human neuronal cells for patients with stroke | Q42492334 |
| | Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection. | Q42754608 |
| | Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat. | Q43980513 |
| | Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model | Q44034622 |
| | Concurrent formation of peroxynitrite with the expression of inducible nitric oxide synthase in the brain during middle cerebral artery occlusion and reperfusion in rats | Q44136679 |
| | The nitroxide antioxidant tempol is cerebroprotective against focal cerebral ischemia in spontaneously hypertensive rats | Q44163905 |
| | Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats | Q44239795 |
| | Melatonin in Chinese medicinal herbs | Q44426550 |
| | Neuroprotection by (-)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress | Q44581012 |
| | Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia | Q45200109 |
| | Melatonin modulates cell survival of new neurons in the hippocampus of adult mice. | Q46022685 |
| | Role of melatonin receptors in the effects of melatonin on BDNF and neuroprotection in mouse cerebellar neurons | Q46584505 |
| | Effect of antioxidants on functional recovery after in vitro-induced ischemia and long-term potentiation recorded in the pyramidal layer of the CA1 area of rat hippocampus | Q46637328 |
| P433 | issue | 5 | |
| P921 | main subject | melatonin | Q180912 |
| P304 | page(s) | 883-891 | |
| P577 | publication date | 2015-10-22 | |
| P1433 | published in | Cell Transplantation | Q15761863 |
| P1476 | title | Melatonin as an Antioxidant for Stroke Neuroprotection | |
| P478 | volume | 25 | |